IL1B and Behcet disease: Corticosteroid treatment of patients with active BD was related to an increase in the IL-37 mRNA and protein levels, suggesting that this treatment may play an immunosuppressive role by regulating the production of IL-37 and reducing the levels of the proinflammatory cytokines IL-1, IL-6, and TNF-α (108).